PL376790A1 - Pochodne 3-fenylopirydoindolonu, sposób ich wytwarzania i ich zastosowanie terapeutyczne - Google Patents
Pochodne 3-fenylopirydoindolonu, sposób ich wytwarzania i ich zastosowanie terapeutyczneInfo
- Publication number
- PL376790A1 PL376790A1 PL376790A PL37679003A PL376790A1 PL 376790 A1 PL376790 A1 PL 376790A1 PL 376790 A PL376790 A PL 376790A PL 37679003 A PL37679003 A PL 37679003A PL 376790 A1 PL376790 A1 PL 376790A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- phenyl substituted
- therapeutic use
- pyridoindolone
- substituted pyridoindolone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0213264A FR2846329B1 (fr) | 2002-10-23 | 2002-10-23 | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL376790A1 true PL376790A1 (pl) | 2006-01-09 |
| PL214867B1 PL214867B1 (pl) | 2013-09-30 |
Family
ID=32088223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376790A PL214867B1 (pl) | 2002-10-23 | 2003-10-21 | Pochodna pirydoindolonu, sposób jej wytwarzania, srodek farmaceutyczny zawierajacy te pochodna oraz zastosowanie tej pochodnej |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7390818B2 (pl) |
| EP (1) | EP1556382B1 (pl) |
| JP (1) | JP4488899B2 (pl) |
| KR (1) | KR101051859B1 (pl) |
| CN (1) | CN100345850C (pl) |
| AR (1) | AR041689A1 (pl) |
| AT (1) | ATE396994T1 (pl) |
| AU (1) | AU2003296769B2 (pl) |
| BR (1) | BR0314883A (pl) |
| CA (1) | CA2502769C (pl) |
| CY (1) | CY1109785T1 (pl) |
| DE (1) | DE60321372D1 (pl) |
| DK (1) | DK1556382T3 (pl) |
| EA (1) | EA010833B1 (pl) |
| ES (1) | ES2304546T3 (pl) |
| FR (1) | FR2846329B1 (pl) |
| HK (1) | HK1074446A1 (pl) |
| HR (1) | HRP20050362B1 (pl) |
| IL (1) | IL168133A (pl) |
| IS (1) | IS2641B (pl) |
| MA (1) | MA27455A1 (pl) |
| ME (1) | ME00102B (pl) |
| MX (1) | MXPA05004349A (pl) |
| NO (1) | NO331297B1 (pl) |
| NZ (1) | NZ539866A (pl) |
| PL (1) | PL214867B1 (pl) |
| PT (1) | PT1556382E (pl) |
| RS (1) | RS51605B (pl) |
| SI (1) | SI1556382T1 (pl) |
| TW (1) | TWI325864B (pl) |
| UA (1) | UA79317C2 (pl) |
| WO (1) | WO2004041817A1 (pl) |
| ZA (1) | ZA200503231B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823975B1 (fr) | 2001-04-27 | 2003-05-30 | Sanofi Synthelabo | Nouvelle utilisation de pyridoindolone |
| US7456193B2 (en) | 2002-10-23 | 2008-11-25 | Sanofi-Aventis | Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| US20100297252A1 (en) * | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| FR2869316B1 (fr) | 2004-04-21 | 2006-06-02 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique. |
| FR2876377B1 (fr) * | 2004-10-11 | 2007-03-16 | Univ Claude Bernard Lyon | Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes |
| FR2892416B1 (fr) * | 2005-10-20 | 2008-06-27 | Sanofi Aventis Sa | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
| FR2945950A1 (fr) | 2009-05-27 | 2010-12-03 | Elan Pharma Int Ltd | Compositions de nanoparticules anticancereuses et procedes pour les preparer |
| HUE032426T2 (en) | 2009-05-27 | 2017-09-28 | Alkermes Pharma Ireland Ltd | Inhibition of flake aggregation in nanoparticulate meloxicam formulations |
| FR2959133A1 (fr) | 2010-04-22 | 2011-10-28 | Sanofi Aventis | Formulation pharmaceutique anticancereuse |
| CN107459481A (zh) * | 2017-07-25 | 2017-12-12 | 广州大学 | 一种3‑（4‑甲氧基苯基）‑6‑甲氧基‑4‑氯‑5,7‑二溴喹啉的合成方法 |
| US12122780B2 (en) * | 2019-02-01 | 2024-10-22 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor |
| CN113329276B (zh) | 2020-02-28 | 2022-10-28 | 华为技术有限公司 | 数据传输方法、装置、网关、芯片及存储介质 |
| CN116171156A (zh) * | 2020-07-31 | 2023-05-26 | 南京明德新药研发有限公司 | 含嘧啶基团的三并环类化合物的盐型、晶型及其制备方法 |
| US20240132446A1 (en) * | 2021-05-26 | 2024-04-25 | Refined Technologies, Inc. | Compositions and methods for removal of n-methyl-2-pyrrolidone (nmp) degradation products and other foulants from nmp purification systems |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1268772A (en) | 1968-03-15 | 1972-03-29 | Glaxo Lab Ltd | NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME |
| US4263304A (en) | 1978-06-05 | 1981-04-21 | Sumitomo Chemical Company, Limited | 7 H-indolo[2,3-c]isoquinolines |
| SU833971A1 (ru) | 1979-07-10 | 1981-05-30 | Ленинградский Химико-Фармацевтическийинститут | Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ |
| FR2595701B1 (fr) | 1986-03-17 | 1988-07-01 | Sanofi Sa | Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant |
| EP0755454B1 (en) | 1994-04-13 | 2008-02-13 | The Rockefeller University | Aav-mediated delivery of dna to cells of the nervous system |
| DE19502753A1 (de) * | 1995-01-23 | 1996-07-25 | Schering Ag | Neue 9H-Pyrido[3,4-b]indol-Derivate |
| FR2765581B1 (fr) * | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique |
| FR2765582B1 (fr) | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique |
| CA2326319A1 (en) | 1998-04-02 | 1999-10-14 | Neurogen Corporation | Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands |
| IT1313592B1 (it) * | 1999-08-03 | 2002-09-09 | Novuspharma Spa | Derivati di 1h-pirido 3,4-b indol-1-one. |
| US20020156016A1 (en) | 2001-03-30 | 2002-10-24 | Gerald Minuk | Control of cell growth by altering cell membrane potentials |
| FR2823975B1 (fr) | 2001-04-27 | 2003-05-30 | Sanofi Synthelabo | Nouvelle utilisation de pyridoindolone |
| FR2846330B1 (fr) | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique |
| US7456193B2 (en) | 2002-10-23 | 2008-11-25 | Sanofi-Aventis | Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics |
| FR2869316B1 (fr) | 2004-04-21 | 2006-06-02 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique. |
| FR2892416B1 (fr) | 2005-10-20 | 2008-06-27 | Sanofi Aventis Sa | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
-
2002
- 2002-10-23 FR FR0213264A patent/FR2846329B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-21 UA UAA200503772A patent/UA79317C2/uk unknown
- 2003-10-21 KR KR20057006949A patent/KR101051859B1/ko not_active IP Right Cessation
- 2003-10-21 WO PCT/FR2003/003110 patent/WO2004041817A1/fr active IP Right Grant
- 2003-10-21 SI SI200331333T patent/SI1556382T1/sl unknown
- 2003-10-21 DE DE60321372T patent/DE60321372D1/de not_active Expired - Lifetime
- 2003-10-21 AU AU2003296769A patent/AU2003296769B2/en not_active Ceased
- 2003-10-21 ME MEP-2008-222A patent/ME00102B/me unknown
- 2003-10-21 BR BR0314883-1A patent/BR0314883A/pt active Pending
- 2003-10-21 NZ NZ539866A patent/NZ539866A/en not_active IP Right Cessation
- 2003-10-21 EA EA200500521A patent/EA010833B1/ru not_active IP Right Cessation
- 2003-10-21 MX MXPA05004349A patent/MXPA05004349A/es active IP Right Grant
- 2003-10-21 CN CNB2003801072280A patent/CN100345850C/zh not_active Expired - Fee Related
- 2003-10-21 ES ES03810495T patent/ES2304546T3/es not_active Expired - Lifetime
- 2003-10-21 AT AT03810495T patent/ATE396994T1/de active
- 2003-10-21 PT PT03810495T patent/PT1556382E/pt unknown
- 2003-10-21 JP JP2004549256A patent/JP4488899B2/ja not_active Expired - Fee Related
- 2003-10-21 EP EP03810495A patent/EP1556382B1/fr not_active Expired - Lifetime
- 2003-10-21 CA CA2502769A patent/CA2502769C/en not_active Expired - Fee Related
- 2003-10-21 RS YU20050362A patent/RS51605B/en unknown
- 2003-10-21 DK DK03810495T patent/DK1556382T3/da active
- 2003-10-21 PL PL376790A patent/PL214867B1/pl unknown
- 2003-10-22 AR ARP030103840A patent/AR041689A1/es unknown
- 2003-10-23 TW TW092129440A patent/TWI325864B/zh not_active IP Right Cessation
-
2005
- 2005-04-19 IL IL168133A patent/IL168133A/en not_active IP Right Cessation
- 2005-04-19 US US11/109,068 patent/US7390818B2/en not_active Expired - Lifetime
- 2005-04-19 MA MA28228A patent/MA27455A1/fr unknown
- 2005-04-20 IS IS7815A patent/IS2641B/is unknown
- 2005-04-21 HR HRP20050362AA patent/HRP20050362B1/hr not_active IP Right Cessation
- 2005-04-21 ZA ZA200503231A patent/ZA200503231B/en unknown
- 2005-04-22 NO NO20051983A patent/NO331297B1/no not_active IP Right Cessation
- 2005-09-23 HK HK05108402A patent/HK1074446A1/xx not_active IP Right Cessation
-
2008
- 2008-05-12 US US12/118,920 patent/US8012991B2/en active Active
- 2008-07-29 CY CY20081100788T patent/CY1109785T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1074446A1 (en) | 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof | |
| HK1076110A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
| IL159275A0 (en) | Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| HK1073070A1 (en) | Novel biomaterials, their preparation and use | |
| TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
| PT1525193E (pt) | Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide | |
| HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
| ZA200210316B (en) | Composition and its therapeutic use. | |
| IL164887A0 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
| GB0219660D0 (en) | Therapeutic use | |
| GB0207410D0 (en) | Compounds and their therapeutic use | |
| PL374858A1 (pl) | Nowe pochodne aryloimidazolu, ich wytwarzanie i ich zastosowania terapeutyczne | |
| HK1065792A1 (en) | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
| GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use | |
| SI1525198T1 (sl) | Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP | |
| SI1525193T1 (sl) | Acilaminotiazolni derivati in njihova uporaba kotinhibitorji beta-amiloida | |
| GB2420345B (en) | 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use | |
| SI1513836T1 (sl) | Derivati piperazinilacilpiperidina, njihova priprava in njihova terapevtska uporaba | |
| SI1513835T1 (sl) | Derivati piperazunilacilpiperidina, njihova priprava in njihova terapevtska uporaba | |
| AU2003209845A1 (en) | Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof | |
| GB0226850D0 (en) | Therapeutic use | |
| GB0226865D0 (en) | Therapeutic use | |
| GB0224787D0 (en) | Therapeutic use | |
| GB0223118D0 (en) | Therapeutic use | |
| GB0229744D0 (en) | New therapeutic use |